273 related articles for article (PubMed ID: 38391997)
21. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469
[TBL] [Abstract][Full Text] [Related]
22. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
23. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
24. Aptamers in neuro-oncology: An emerging therapeutic modality.
Doherty C; Wilbanks B; Khatua S; Maher LJ
Neuro Oncol; 2024 Jan; 26(1):38-54. PubMed ID: 37619244
[TBL] [Abstract][Full Text] [Related]
25. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
26. Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications.
Kara N; Ayoub N; Ilgu H; Fotiadis D; Ilgu M
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175137
[TBL] [Abstract][Full Text] [Related]
27. Advances in Oligonucleotide Aptamers for NSCLC Targeting.
Rotoli D; Santana-Viera L; Ibba ML; Esposito CL; Catuogno S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842557
[TBL] [Abstract][Full Text] [Related]
28. Capture-SELEX: Selection Strategy, Aptamer Identification, and Biosensing Application.
Lam SY; Lau HL; Kwok CK
Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551109
[TBL] [Abstract][Full Text] [Related]
29. Aptamers as remarkable diagnostic and therapeutic agents in cancer treatment.
Lassalle HP; Marchal S; Guillemin F; Reinhard A; Bezdetnaya L
Curr Drug Metab; 2012 Oct; 13(8):1130-44. PubMed ID: 22380008
[TBL] [Abstract][Full Text] [Related]
30. Advanced screening and tailoring strategies of pesticide aptamer for constructing biosensor.
Li T; Wang J; Zhu L; Li C; Chang Q; Xu W
Crit Rev Food Sci Nutr; 2023; 63(31):10974-10994. PubMed ID: 35699641
[TBL] [Abstract][Full Text] [Related]
31. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
32. The application of aptamers in cancer research: an up-to-date review.
Hu M; Zhang K
Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
[TBL] [Abstract][Full Text] [Related]
33. Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach.
Khedri M; Abnous K; Rafatpanah H; Nabavinia MS; Taghdisi SM; Ramezani M
Immunol Invest; 2020 Jul; 49(5):535-554. PubMed ID: 32429721
[TBL] [Abstract][Full Text] [Related]
34. Aptamers selected by cell-SELEX for application in cancer studies.
Zhang Y; Chen Y; Han D; Ocsoy I; Tan W
Bioanalysis; 2010 May; 2(5):907-18. PubMed ID: 20657791
[TBL] [Abstract][Full Text] [Related]
35. [Preparation of dual-functional composite magnetic nanomaterials modified with different metals/aptamers and their performance in exosome enrichment].
Zhang W; Lu R; Zhang L
Se Pu; 2021 Oct; 39(10):1128-1136. PubMed ID: 34505435
[TBL] [Abstract][Full Text] [Related]
36. Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders.
Basu D; Chakraborty S; Pal R; Sharma TK; Sarkar S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575825
[TBL] [Abstract][Full Text] [Related]
37. Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications.
Vázquez-González M; Willner I
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670386
[TBL] [Abstract][Full Text] [Related]
38. Novel insights into the role of aptamers in the fight against cancer.
Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
[TBL] [Abstract][Full Text] [Related]
39. Oligonucleotide aptamers for glioma targeting: an update.
Camorani S; Cerchia L
Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acid aptamers: an emerging frontier in cancer therapy.
Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W
Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
